Who makes Cohort B1: Lu AE58054?

Cohort B1: Lu AE58054 is developed by H. Lundbeck A/S.

What development phase is Cohort B1: Lu AE58054 in?

Cohort B1: Lu AE58054 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Cohort B1: Lu AE58054

H. Lundbeck A/S · Phase 1 active Small molecule

At a glance

Generic name	Cohort B1: Lu AE58054
Sponsor	H. Lundbeck A/S
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cohort B1: Lu AE58054 CI brief — competitive landscape report
Cohort B1: Lu AE58054 updates RSS · CI watch RSS
H. Lundbeck A/S portfolio CI